443

Compound name
Acalabrutinib
Alt Name
ACP-196
Calquence
Compound Image
Acalabrutinib.png
SMILES
CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5
MW
465.50
Brutto
C26H23N7O2
InChI
InChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m0/s1
InChI Key
WDENQIQQYWYTPO-IBGZPJMESA-N
Approval Jurisdiction
2017 FDA 2018 EMA
Approved for clinical use
Mantle Cell Lymphoma, CLL
CAS
1420477-60-6
PubChem CID
71226662
Action
BTK
Approved Drug List
1
Commercial Vendor
AstraZeneca Acerta Pharma